These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16698375)

  • 1. Lift-assisted offset lithotomy: positioning for transurethral operations in morbidly obese.
    Fisher MB; Broghammer J; Stefanou A; Triest JA
    Urology; 2006 May; 67(5):1084.e1-3. PubMed ID: 16698375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of sarcomatoid carcinoma of the urinary bladder].
    Hosokawa Y; Kuwada M; Kumamoto H; Hayashi Y; Fujimoto K; Hirao Y
    Hinyokika Kiyo; 2008 Aug; 54(8):561-3. PubMed ID: 18788448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hand assisted retroperitoneoscopic nephroureterectomy with the patient spread-eagled: an approach through a completely supine position.
    Ou CH; Yang WH
    J Urol; 2008 Nov; 180(5):1918-22; discussion 1922. PubMed ID: 18801531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity among the morbidly obese: a comparative study of 2002 U.S. hospital patient discharges.
    Scott SK; Rabito FA; Price PD; Butler NN; Schwartzbaum JA; Jackson BM; Love RL; Harris RE
    Surg Obes Relat Dis; 2006; 2(2):105-11. PubMed ID: 16925332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Membranous glomerulonephritis and transitional cell carcinoma, improved proteinuria after each tumor resection].
    Fabbian F; Rizzioli E; Catalano C
    G Ital Nefrol; 2003; 20(1):65-8. PubMed ID: 12647289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H;
    Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric surgery in paediatrics--when and how?
    Fried M
    Int J Pediatr Obes; 2008 Oct; 3 Suppl 2():15-9; discussion 20. PubMed ID: 18850407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and changes in comorbidities after bariatric surgery.
    Perry CD; Hutter MM; Smith DB; Newhouse JP; McNeil BJ
    Ann Surg; 2008 Jan; 247(1):21-7. PubMed ID: 18156918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic neobladder for bladder cancer and neurogenic bladder dysfunction.
    Maurice MJ; Meeks JJ; Smith ND
    Can J Urol; 2008 Aug; 15(4):4194-5. PubMed ID: 18706153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some anesthetic aspects of morbid obesity.
    Sinha AC
    Curr Opin Anaesthesiol; 2009 Jun; 22(3):442-446. PubMed ID: 19412093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
    Schmidbauer J; Lindenau G
    Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic management of morbidly obese and super-morbidly obese patients undergoing bariatric operations: hospital course and outcomes.
    Leykin Y; Pellis T; Del Mestro E; Marzano B; Fanti G; Brodsky JB
    Obes Surg; 2006 Dec; 16(12):1563-9. PubMed ID: 17217630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic diagnosis and treatment of superficial bladder tumors].
    Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):1023-30. PubMed ID: 11769072
    [No Abstract]   [Full Text] [Related]  

  • 19. Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy.
    Dangle PP; Wang WP; Mayerson J; Mortazavi A; Monk P
    World J Surg Oncol; 2008 Sep; 6():103. PubMed ID: 18826578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and morbid obesity are associated with a greater conversion rate to open surgery for standard but not hand assisted laparoscopic radical nephrectomy.
    Gabr AH; Elsayed ER; Gdor Y; Roberts WW; Wolf JS
    J Urol; 2008 Dec; 180(6):2357-62; discussion 2362. PubMed ID: 18930284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.